Axitinib beyond first-line therapy of Metastatic Renal Cell Carcinoma: Real World Data from the STAR-TOR registry

Uhlig, A; Uhlig, J; Woike, M; Fischer, T; Trojan, L; Bergmann, L; Goebell, PJ; Rink, M; Schlack, K; Leitsmann, M; Strauss, A

Uhlig, A (通讯作者)，Univ Med Ctr Goettingen, Dept Urol, Robert Koch Str 40, D-37075 Gottingen, Germany.

KIDNEY CANCER, 2023; 7 (1): 37

Abstract

Objective: To evaluate the effectiveness and safety profile of the tyrosine kinase inhibitor Axitinib for patients with advanced or metastatic renal c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索